Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)

Verfasser / Beitragende:
[S. Leyvraz, M. Bacchi, T. Cerny, A. Lissoni, C. Sessa, A. Bressoud, R. Hermann]
Ort, Verlag, Jahr:
1998
Enthalten in:
Annals of Oncology, 9/8(1998-08), 877-84
Format:
Artikel (online)
ID: 439513243